ROXANA LOPEZ: Open Payments
NPI 1598278848 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$820 in 35 payments from 14 companies in 2025. Trend: 2023 $661 · 2024 $526 · 2025 $820
Food & beverage: $820
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $279 |
| ABBVIE INC. | 5 | $106 |
| Lilly USA, LLC | 4 | $77 |
| GlaxoSmithKline, LLC. | 3 | $75 |
| Abbott Laboratories | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Amgen Inc. | 2 | $38 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $33 |
| PFIZER INC. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
Products named: Ozempic, MOUNJARO, TRELEGY ELLIPTA, VRAYLAR, Wegovy, JARDIANCE, UBRELVY, OTEZLA.
Industry payments across TX — which companies pay providers there.
